Jonathan Javitt
2021
In 2021, Jonathan Javitt earned a total compensation of $377.3K as Director and Former Chief Executive Officer at NRX Pharmaceuticals, a 39% decrease compared to previous year.
Compensation breakdown
| Salary | $275,000 |
|---|---|
| Other | $102,287 |
| Total | $377,287 |
Javitt received $275K in salary, accounting for 73% of the total pay in 2021.
Javitt also received $102.3K in other compensation.
Rankings
In 2021, Jonathan Javitt's compensation ranked 11,267th out of 12,415 executives tracked by ExecPay. In other words, Javitt earned more than 9.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,267 out of 12,415 | 9th |
Division Manufacturing | 4,979 out of 5,505 | 10th |
Major group Chemicals And Allied Products | 2,211 out of 2,375 | 7th |
Industry group Drugs | 1,966 out of 2,096 | 6th |
Industry Pharmaceutical Preparations | 1,458 out of 1,546 | 6th |
Source: SEC filing on June 17, 2022.
Javitt's colleagues
We found three more compensation records of executives who worked with Jonathan Javitt at NRX Pharmaceuticals in 2021.